Clinical and economic impact of compression in the acute phase of deep vein thrombosis

Amin, Elham E.; Joore, Manuela A.; Cate, Hugo Ten; Meijer, Karina; Tick, Lidwine W.; Middeldorp, Saskia; Mostard, Guy J M; Wolde, Marije ten; Heiligenberg, Simone M. van den; Wissen, Sanne van; Poel, Marlène H. W. van de; Villalta, Sabina; Serné, Erik H.; Otten, Hans-Martin; Klappe, E. H.; Prandoni, Paolo; Cate‐Hoek, Arina J. ten

doi:10.1111/jth.14163

Cited by 23 publications

(14 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The effectiveness of compression therapy with good adherence as prophylaxis against PTS was shown again in the recently published OCTAVIA and IDEAL studies [32,33]. A sub-study of the IDEAL study also showed that starting compression therapy immediately rather than after 2 weeks led to significantly lower objective PTS parameters in the Villalta score [34].…”

Section: Prophylaxis Of Ptsmentioning

confidence: 86%

“…The OCTAVIA and IDEAL studies have recently confirmed that compression therapy with good adherence can significantly reduce the incidence of PTS [32,33]. The latest outcomes from the IDEAL study have also shown a reduction in the incidence of PTS when compression therapy is started immediately compared to delayed start [34]. In view of the above, the following is recommended:…”

Section: Indications For Medical Compression Therapy Recommendation 28mentioning

confidence: 99%

“…Nelson investigated the effect of compression therapy on recurrent venous leg ulcer [ (34)(35)(36)(37)(38)(39)(40)(41)(42)(43)(44)(45)(46) for prophylaxis of ulcer recurrence in patients in a nursing home [67]. The risk of recurrence was higher with CCL II, but adherence to the compression therapy was low at 44%.…”

Section: Prevention Of Recurrent Venous Leg Ulcermentioning

confidence: 99%

See 2 more Smart Citations

Medical compression therapy of the extremities with medical compression stockings (MCS), phlebological compression bandages (PCB), and medical adaptive compression systems (MAC)

Rabe

Földi²,

Gerlach³

et al. 2021

Hautarzt

View full text Add to dashboard Cite

Section: Prophylaxis Of Ptsmentioning

confidence: 86%

Section: Indications For Medical Compression Therapy Recommendation 28mentioning

confidence: 99%

Section: Prevention Of Recurrent Venous Leg Ulcermentioning

confidence: 99%

See 1 more Smart Citation

Medical compression therapy of the extremities with medical compression stockings (MCS), phlebological compression bandages (PCB), and medical adaptive compression systems (MAC)

Rabe

Földi²,

Gerlach³

et al. 2021

Hautarzt

View full text Add to dashboard Cite

“…showed that immediate start of compression can significantly reduce the objective parameters of PTS using the Villalta scale after 3 months compared to delayed start of compression. 29 , 30…”

Section: Discussionmentioning

confidence: 99%

Compression treatment in acute symptomatic proximal deep venous thrombosis – Results of a worldwide survey

et al. 2021

View full text Add to dashboard Cite

Objectives The aim of this study was to illustrate how compression is performed worldwide in proximal DVT and if compression management has changed recently. Methods A global online survey, consisting of 36 questions, was used. The survey was solicited from membership lists of Union Internationale de Phlébologie (UIP) membership societies. For differences between the continents in comparison to Western Europe odds ratios and 95% Confidence Intervals (95%CI) where calculated. Results We received 626 answers from 41 countries. Compression is routinely used in proximal DVT in all regions (82.8%). 81.4% start compression immediately after diagnosis. In the acute phase of DVT reduction of pain and swelling (91.7%) and PTS prevention (66.2%) are the main reasons for compression. 33.2% recently changed their compression management with 43.5% starting compression earlier and 7.0% later. Conclusions Compression is still used routinely in proximal DVT in addition to anticoagulation. The changes in international guidelines towards the non-routine use of compression in proximal DVT have not caused significant changes in DVT management.

show abstract

“…[39][40][41][67][68][69] There are no data suggesting that compression of veins filled with clots may lead to an increased risk of PE or post-thrombotic syndrome (PTS). 39,41,63,64,70,71 Recommendation 18. We recommend considering that, in contrast to previous concepts, compression is not contraindicated in acute thrombotic events, but results in favourable clinical outcomes when applied with caution.…”

Section: Deep and Superficial Vein Thrombosismentioning

confidence: 99%

Risks and contraindications of medical compression treatment – A critical reappraisal. An international consensus statement

Rabe

Partsch

Morrison³

et al. 2020

Phlebology

View full text Add to dashboard Cite

Objectives Medical compression therapy is used for non-invasive treatment of venous and lymphatic diseases. Medical compression therapy-associated adverse events and contraindications have been reported, although some contraindications are theoretically based. This consensus statement provides recommendations on medical compression therapy risks and contraindications. Methods A systematic literature search of medical compression therapy publications reporting adverse events up until November 2017 was performed. A consensus panel comprising 15 international experts critically reviewed the publications and formulated the recommendations. Results Sixty-two publications reporting medical compression therapy adverse events were identified. The consensus panel issued 21 recommendations on medical compression therapy contraindications and adverse event risk mitigation, in addition to reviewing medical compression therapy use in borderline indications. The most frequently reported non-severe medical compression therapy-associated adverse events included skin irritation, discomfort and pain. Very rare but severe adverse events, including soft tissue and nerve injury, were also identified. Conclusion This consensus statement summarises published medical compression therapy-associated adverse events and contraindications, and provides guidance on medical compression therapy. Severe medical compression therapy-associated adverse events are very rarely encountered if compression is used correctly and contraindications are considered.

show abstract

Clinical and economic impact of compression in the acute phase of deep vein thrombosis

Abstract: IDEAL DVT study ClinicalTrials.gov number, NCT01429714.

Cited by 23 publications

References 25 publications

Medical compression therapy of the extremities with medical compression stockings (MCS), phlebological compression bandages (PCB), and medical adaptive compression systems (MAC)

Medical compression therapy of the extremities with medical compression stockings (MCS), phlebological compression bandages (PCB), and medical adaptive compression systems (MAC)

Compression treatment in acute symptomatic proximal deep venous thrombosis – Results of a worldwide survey

Risks and contraindications of medical compression treatment – A critical reappraisal. An international consensus statement

Contact Info

Product

Resources

About